MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple threat: gene therapy joins forces with chemo and immuno to fight bladder cancer
Disease control Not yet recruitingThis study tests whether adding a gene therapy (nadofaragene firadenovec) to standard chemotherapy and immunotherapy before bladder removal surgery can improve outcomes for people with muscle-invasive bladder cancer. About 33 participants will receive the combination treatment, t…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 17, 2026 06:51 UTC
-
New combo aims to spare bladder in aggressive cancer without removing the organ
Disease control Not yet recruitingThis study tests whether a mix of immunotherapy (toripalimab), targeted therapy (RC48-ADC), and radiation can help people with HER2-positive muscle-invasive bladder cancer keep their bladder after initial chemotherapy. About 45 adults with stage T2-T4aN0M0 disease will receive th…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC